NCCN Clinical Practice Guidelines in Oncology Update Recommends BESREMi® (ropeginterferon alfa-2b-njft) for the Treatment of Polycythemia Vera
Business Wire,
Reflecting its strong clinical profile and broad label, NCCN Guidelines include BESREMi as an option for PV regardless of…